NORTH CHICAGO, Ill. , Dec. 1, 2020 /PRNewswire/ -- AbbVie (NYSE: ABBV) will host a virtual immunology strategic update for investors on Monday, December 14, 2020 at 9:00 a.m. Central time . Richard A. Gonzalez , chairman of the board and chief executive officer, and members of the executive

NORTH CHICAGO, Ill. , Nov. 24, 2020 /PRNewswire/ -- AbbVie (NYSE: ABBV) will participate in the Evercore ISI Virtual HealthCONx Conference on Wednesday, December 2 at 1:40 p.m. CT and the Piper Sandler Virtual Healthcare Conference on Thursday, December 3 at 10 a.m. CT .

NORTH CHICAGO, Ill. , Nov. 12, 2020 /PRNewswire/ -- AbbVie (NYSE: ABBV) will participate in the Wolfe Research Healthcare Conference on Thursday, November 19, 2020 . Michael Severino , M.D., vice chairman and president, and Robert A. Michael , executive vice president and chief financial officer,

- Reports Third-Quarter Diluted EPS of $1.29 on a GAAP Basis; Adjusted Diluted EPS of $2.83   - Delivers Third-Quarter Net Revenues of $12.902 Billion on a GAAP Basis, an Increase of 52.1 Percent on a Reported Basis; Adjusted Net Revenues Were $12.882 Billion   - Third-Quarter Global Net Revenues

NORTH CHICAGO, Ill. , Oct. 6, 2020 /PRNewswire/ -- AbbVie (NYSE: ABBV) will announce its third-quarter 2020 financial results on Friday, October 30, 2020 , before the market opens. AbbVie will host a live webcast of the earnings conference call at 8 a.m. Central time .

NORTH CHICAGO, Ill. , Sept. 11, 2020 /PRNewswire/ -- The board of directors of AbbVie Inc. (NYSE: ABBV) today declared a quarterly cash dividend of $1.18 per share.  The cash dividend is payable November 16, 2020 to stockholders of record at the close of business on October 15, 2020 .

NORTH CHICAGO, Ill. , Sept. 3, 2020 /PRNewswire/ -- AbbVie (NYSE: ABBV) will participate in the Morgan Stanley 18th Annual Global Healthcare Conference on Wednesday, September 16, 2020 .  Richard A. Gonzalez , chairman and chief executive officer, will present at 10 a.m. Central time .

- On May 8, 2020, AbbVie Completed its Acquisition of Allergan, Significantly Expanding and Diversifying AbbVie's Revenue Base with New Therapeutic Areas, Enhancing Long-Term Growth Potential, and Enabling Investment in Innovation for each of its Therapeutic Categories   - Reports Second-Quarter

NORTH CHICAGO, Ill. , July 7, 2020 /PRNewswire/ -- AbbVie (NYSE: ABBV) will announce its second-quarter 2020 financial results on Friday, July 31, 2020 , before the market opens. AbbVie will host a live webcast of the earnings conference call at 8 a.m. Central time .

NORTH CHICAGO, Ill. , June 17, 2020 /PRNewswire/ -- The board of directors of AbbVie Inc. (NYSE: ABBV) today declared a quarterly cash dividend of $1.18 per share.  The cash dividend is payable August 14, 2020 to stockholders of record at the close of business on July 15, 2020 .